Cutaneous immune cell levels in patients with hard-to-heal wounds after maggot therapy and surgical debridement therapy
Journal of Wound Care · 2025
DOI: 10.12968/jowc.2023.0186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Wound Care, 2025. Verfasst von Umut Gazi und 6 weiteren Autor:innen. Beteiligte Einrichtung: PhD, Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus. Hauptthemen laut MEDLINE: Debridement, Wound Healing, Larva, Diabetic Foot. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to investigate and compare the effects of maggot therapy (MT) and surgical debridement therapy (SDT) on the inflammatory phase of healing, a phase which does not favour tissue regeneration in hard-to-heal wounds.
Method
SDT was performed in sterile operating theatre conditions. MT was applied with a dose of 5–7 maggots/cm 2 . The levels of neutrophils, macrophages, M1 cells, M2 cells, T-cells and B-cells were analysed by using flow cytometry analysis which was performed on wound biopsy samples collected from hard-to-heal foot ulcers in patients with diabetes before and after either SDT or MT.
Results
The experimental cohort comprised 25 patients. Patients in the MT group (n=13) demonstrated a shorter time to complete debridement, required fewer debridement sessions and had a higher rate of complete recovery than patients in the SDT group (n=12). Both therapies were able to reduce neutrophil, macrophage and M1 cell levels, and to elevate M2 cell, T-cell and B-cell frequencies. Statistically significantly higher variations were reported after MT than after SDT in neutrophil, M2 cell, T-cell and B-cell counts.
Conclusion
The higher cell numbers detected in the MT group could be associated with an increased healing rate and reduced debridement time in comparison with SDT. MT not only debrided the wound effectively, but also positively influenced wound healing through its effect on the inflammatory process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PhD, Department of Medical Microbiology and Clinical Microbiology, Faculty of Medicine, Near East University, Nicosia, Cyprus.
- MD, Department of General Surgery, Faculty of Medicine, Selcuk University, Konya, Turkey.
- PhD, Department of General Surgery, Faculty of Medicine, Izmir Bakırçay University, Izmir, Turkey.
- PhD, Department of Biostatistics, Faculty of Medicine, Near East University, Nicosia, Cyprus.
- DVM, PhD, Department of Medical Microbiology, Faculty of Medicine, Selcuk University, Konya, Turkey.
- PhD, Parasitology Unit, Department of Microbiology and Molecular Genetics, The Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
ORCID-Profile: Umut Gazi
Zitieren
APA
Gazi, U., Colak, B., Tosun, O., Sahin, M., Uslu, U., Mumcuoglu, K. Y., & Taylan-Ozkan, A. (2025). Cutaneous immune cell levels in patients with hard-to-heal wounds after maggot therapy and surgical debridement therapy. Journal of Wound Care. https://doi.org/10.12968/jowc.2023.0186
Vancouver
Gazi U, Colak B, Tosun O, Sahin M, Uslu U, Mumcuoglu KY, et al. Cutaneous immune cell levels in patients with hard-to-heal wounds after maggot therapy and surgical debridement therapy. Journal of Wound Care. 2025. doi:10.12968/jowc.2023.0186
BibTeX
@article{Gazi2025,
author = {Gazi, Umut and Colak, Bayram and Tosun, Ozgur and Sahin, Mustafa and Uslu, Ugur and Mumcuoglu, Kosta Y and Taylan-Ozkan, Aysegul},
title = {Cutaneous immune cell levels in patients with hard-to-heal wounds after maggot therapy and surgical debridement therapy},
journal = {Journal of Wound Care},
year = {2025},
doi = {10.12968/jowc.2023.0186}
}
EUVIMED